FDA Letter API

LJ's E-Smokes LLC

Letter data

Company
LJ's E-Smokes LLC
Recipient
Henry Williams | LJ's E-Smokes LLC | United States | support@ljesmokes.com | henry@ljesmokes.com
Issue date
2022-05-27
Posted date
Not available
FDA office
Center for Tobacco Products
Subject
Not available
Product
Tobacco
CMS ID
614221
Reference number
RW2101573
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: 21-CFR-PART-114021-CFR-PART-1141

21 U.S.C.: 21-USC-301

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER LJ's E-Smokes LLC MARCS-CMS 614221 — May 27, 2022 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: RW2101573 Product: Tobacco Recipient: Recipient Name Henry Williams LJ's E-Smokes LLC United States support@ljesmokes.com henry@ljesmokes.com Issuing Office: Center for Tobacco Products United States Dear Henry Williams: The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated April 27, 2021 and May 13, 2021 to our Warning Letter dated April 9, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website http://www.ljesmokes.com. However, our surveillance shows you continue to offer for sale to customers in the United States other tobacco products that may be subject to market authorization requirements. FDA encourages you to discuss with your suppliers the current status of any particular tobacco product’s marketing application or authorization. For additional information regarding the marketing status of tobacco products that a company generally might manufacture, distribute, or sell, please visit our website https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/deemed-new-tobacco-product-applications-lists?utm_medium=email&utm_source=govdelivery#list%20of%20deemed This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with each applicable provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and FDA’s implementing regulations or with other relevant legal authority. Please note that if your firm is found to be in violation of the FD&C Act, 21 U.S.C. § 301 et seq., Chapter IX, relating to tobacco products including the tobacco regulations in 21 C.F.R. Parts 1140, 1141, and 1143 in the future, this may lead to regulatory action, including, but not limited to, civil money penalties, seizure, and/or injunction. Sincerely, /S/ David Rice Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products VIA Electronic Mail cc: Contact Privacy, Inc. Customer 0146209974 ljesmokes.com@contactprivacy.com Tucows Domains Inc. domainabuse@tucows.com InMotion Hosting, Inc. abuse@inmotionhosting.com Content current as of: 06/08/2022 Regulated Product(s) Tobacco